Long-Term Efficacy of Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: Data from a Pivotal Phase 3 Clinical Trial

Main Article Content

Alan Menter
Jeff Sobell
Jonathan I Silverberg
Mark Lebwohl
Shipra Rastogi
Radhakrishnan Pillai
Robert J Israel


psoriasis, brodalumab, clinical trial


Abstract not available.


This study was sponsored by Amgen Inc. and medical writing support was funded by Ortho Dermatologics.